Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Guidant/EVT Lesson Learned: Post Senior Compliance Execs To Acquired Unit

This article was originally published in The Gray Sheet

Executive Summary

Integration of a parent firm's adverse event reporting and compliance structure into a subsidiary should begin immediately upon acquisition, as illustrated by Guidant's experience with Menlo Park, Calif. unit Endovascular Technologies

You may also be interested in...



FDA May Wield Prosecutorial Authority More Frequently

Device companies can expect more active legal prosecution by FDA for off-label and product safety issues as the agency improves its ability to track products on the market and as the activity of industry whistleblowers grows, according to government and agency staffers

FDA May Wield Prosecutorial Authority More Frequently

Device companies can expect more active legal prosecution by FDA for off-label and product safety issues as the agency improves its ability to track products on the market and as the activity of industry whistleblowers grows, according to government and agency staffers

Guidant Ancure resolution

Guidant fulfills its obligations related to June 12 plea agreement by meeting "specific requirements around the [abdominal aortic aneurysm] EVT business with reporting and having third parties also look at any events" and by instituting "training mechanisms across the rest of the firm," CEO and President Ron Dollens explains at JPMorgan annual healthcare conference Jan. 12. Of 15 lawsuits relating to improper reporting by the firm's EVT unit of Ancure AAA stent-graft adverse events, 11 have been settled, Dollens adds (1"The Gray Sheet" June 23, 2003, p. 15)...

Related Content

UsernamePublicRestriction

Register

OM016204

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel